The announcement from Alexion is an update to a previous voluntary recall of two specific lots of Soliris asking that any unused vials at the distributor level be returned.
The two recalled lots had visible particles in the solution, posing potential immunogenicity and thromboembolic risks, according to the recall.
More Articles on Medical Recalls:
Abbott Recalls Certain Lots of FreeStyle, FreeStyle Lite Blood Glucose Test Strips
CLR Medicals International Issues Recall on Viscocel, Viscocel Plus
FDA Recalls Spacelabs Healthcare’s Anesthesia Workstations
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
